0001487371-16-000192.txt : 20160125 0001487371-16-000192.hdr.sgml : 20160125 20160125194700 ACCESSION NUMBER: 0001487371-16-000192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160121 FILED AS OF DATE: 20160125 DATE AS OF CHANGE: 20160125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GenMark Diagnostics, Inc. CENTRAL INDEX KEY: 0001487371 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 272053069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (760) 448-4300 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MASSARANY HANY CENTRAL INDEX KEY: 0001134554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34753 FILM NUMBER: 161359769 MAIL ADDRESS: STREET 1: 1910 INNOVATION PARK DR CITY: TUCSON STATE: AZ ZIP: 85737 4 1 wf-form4_145376920927739.xml FORM 4 X0306 4 2016-01-21 0 0001487371 GenMark Diagnostics, Inc. GNMK 0001134554 MASSARANY HANY 5964 LA PLACE COURT CARLSBAD CA 92008 1 1 0 0 President and CEO Common Stock 2016-01-21 4 M 0 1466 0 A 80205 D Common Stock 2016-01-21 4 S 0 648 6.80 D 79557 D Common Stock 406729 I Massarany Family Trust dated November 15, 2012 Market Stock Units 0.0 2016-01-21 4 M 0 1466 0 D Common Stock 1466.0 46584 D The reporting person transferred 818 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable market stock units ("MSUs") vesting event. The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted MSUs. Mr. Massarany is the trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein. Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index. The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. /s/ Eric Stier, Attorney-in-fact 2016-01-25